Warning Letter Roundup & Recap – August 2022
The US FDA handed warning letters to three manufacturers last month, including a COVID-19 test company as well as two infusion firms under the same ownership.
You may also be interested in...
A full appraisal by the UK cost watchdog is not the only way to gauge the safety and effectiveness of Evusheld, argues the independent Drug Safety Research Unit in response to the government’s decision not to buy the licensed COVID-19 drug because of insufficient data on protection.
Torrent’s $245m acquisition of Curatio Healthcare has moved it up a rank to No.7 in the overall Indian pharmaceutical market apart from making it the market leader in cosmetic dermatology. While it’s a pricey deal, factors like growing prevalence of skin diseases and shift towards e-commerce bode well for future revenue growth in a nascent market
China is knocking on the door of the world’s top 10 most innovative economies, helped by sustained investment.